PREVAIL trial

Study / Research

The ongoing outcome study for Obicetrapib, designed to show cardiovascular benefits on top of statins in a high-risk ASCVD population. Expected to read out this year or next.

Mentioned in 1 video

Videos Mentioning PREVAIL trial

407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more

407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more

Peter Attia MD

The ongoing outcome study for Obicetrapib, designed to show cardiovascular benefits on top of statins in a high-risk ASCVD population. Expected to read out this year or next.